Michel Boisbrun
- Organic Chemistry top 5%
- Molecular Biology
- Pharmacology top 10%
- Pharmacology top 5%
- Oncology
- Co-authors
- Yves ChapleurStéphane FlamentIsabelle Grillier‐VuissozSabine MazerbourgSandra KuntzJános SápiJean‐Yves LaronzeDominique Laurain‐Mattar
- Topics
- Peroxisome Proliferator-Activated Receptors (11 papers)Chemical synthesis and alkaloids (6 papers)Metabolism, Diabetes, and Cancer (5 papers)
- Cited by
- Organic ChemistryPharmacology
- Journals
- Journal of Biological ChemistryInternational Journal of Molecular SciencesJournal of Medicinal Chemistry
- Partner nations
- FrancePolandSouth Korea
In The Last Decade
Michel Boisbrun
40 papers receiving 758 citations
Peers
Comparison fields: 5 of 83
- Organic Chemistry 397
- Molecular Biology 337
- Pharmacology 120
- Pharmacology 82
- Oncology 78
Countries citing papers authored by Michel Boisbrun
This map shows the geographic impact of Michel Boisbrun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Boisbrun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Boisbrun more than expected).
Fields of papers citing papers by Michel Boisbrun
This network shows the impact of papers produced by Michel Boisbrun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Boisbrun. The network helps show where Michel Boisbrun may publish in the future.
Co-authorship network of co-authors of Michel Boisbrun
This figure shows the co-authorship network connecting the top 25 collaborators of Michel Boisbrun. A scholar is included among the top collaborators of Michel Boisbrun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Boisbrun. Michel Boisbrun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 3 | |
| 5 | 19 | |
| 6 | 7 | |
| 7 | 6 | |
| 8 | 10 | |
| 9 | 26 | |
| 10 | 21 | |
| 11 | 9 | |
| 12 | 57 | |
| 13 | 28 | |
| 14 | 17 | |
| 15 | 22 | |
| 16 | 14 | |
| 17 | 31 | |
| 18 | 74 | |
| 19 | 17 | |
| 20 | 61 |
About Michel Boisbrun
Michel Boisbrun is a scholar working on Pharmacology, Organic Chemistry and Cancer Research, having authored 40 papers that have together received 767 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (11 papers), Chemical synthesis and alkaloids (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). The work is most often cited by research in Organic Chemistry (397 citations), Pharmacology (82 citations) and Pharmacology (120 citations). Michel Boisbrun has collaborated with scholars based in France, Poland and South Korea. Frequent co-authors include Yves Chapleur, Stéphane Flament, Isabelle Grillier‐Vuissoz, Sabine Mazerbourg, Sandra Kuntz, János Sápi, Jean‐Yves Laronze, Dominique Laurain‐Mattar, Agata Ptak and François Dupire. Their work appears in journals such as Journal of Biological Chemistry, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.